Effects of Mycoplasma pneumoniae infection on airway neurokinin-1 receptor expression in BALB/c mice

Genetics and Molecular Research

Volumn 13, Issue 4, 2014, Pages 8320-8328

  Zhang, H ^a   Wei, B ^b   Shang, Y X ^a   Jiao, X Y ^a   Wang, L ^a   He, M B ^a   Han, X H ^a   Wang, G Z ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

^b Department of Pediatrics Military Hospital of China   (China)

Author keywords

BALB c mouse; Mycoplasma pneumonia; NK1 R

Indexed keywords

NEUROKININ 1 RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BAGG ALBINO MOUSE; BRONCHUS MUCOSA; CONTROLLED STUDY; EPITHELIUM CELL; FEMALE; IMMUNOHISTOCHEMISTRY; LUNG ALVEOLUS EPITHELIUM; LUNG PARENCHYMA; MALE; MOUSE; MYCOPLASMA PNEUMONIA; MYCOPLASMA PNEUMONIAE; NONHUMAN; PROTEIN EXPRESSION; SMOOTH MUSCLE; SUBMUCOSA; TIME; TRACHEA; UPREGULATION; WESTERN BLOTTING; WHEEZING; ANIMAL; DISEASE MODEL; GENE EXPRESSION; GENETICS; LUNG; METABOLISM; MICROBIOLOGY; RESPIRATORY TRACT MUCOSA;

MUS; MYCOPLASMA; MYCOPLASMA PNEUMONIAE;

ANIMALS; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; LUNG; MALE; MICE; MICE, INBRED BALB C; MYCOPLASMA PNEUMONIAE; PNEUMONIA, MYCOPLASMA; RECEPTORS, NEUROKININ-1; RESPIRATORY MUCOSA; TRACHEA;

EID: 84908265637     PISSN: None     EISSN: 16765680     Source Type: Journal    
DOI: 10.4238/2014.October.20.8     Document Type: Article

References (27)

1. Annagür A, Kendirli SG, Yilmaz M, Altintas DU, et al. (2007). Is there any relationship between asthma and asthma attack in children and atypical bacterial infections; Chlamydia pneumoniae, Mycoplasma pneumoniae and Helicobacter pylori. J. Trop. Pediatr. 53: 313-318.
2. Biscardi S, Lorrot M, Marc E, Moulin F, et al. (2004). Mycoplasma pneumoniae and asthma in children. Clin. Infect. Dis. 38: 1341-1346.
3. Bisgaard H, Hermansen MN, Buchvald F, Loland L, et al. (2007). Childhood asthma after bacterial colonization of the airway in neonates. N. Engl. J. Med. 357: 1487-1495.
4. Blasi F and Johnston SL (2007). The role of antibiotics in asthma. Int. J. Antimicrob. Agents 29: 485-493.
5. Chu HW, Kraft M, Krause JE, Rex MD, et al. (2000). Substance P and its receptor neurokinin 1 expression in asthmatic airways. J. Allergy Clin. Immunol. 106: 713-722.
6. Chu HW, Rino JG, Wexler RB, Campbell K, et al. (2005). Mycoplasma pneumoniae infection increases airway collagen deposition in a murine model of allergic airway inflammation. Am. J. Physiol. Lung Cell Mol. Physiol. 289: L125-L133.
7. Chu HW, Breed R, Rino JG, Harbeck RJ, et al. (2006). Repeated respiratory Mycoplasma pneumoniae infections in mice: effect of host genetic background. Microbes. Infect. 8: 1764-1772.
8. Cosentini R, Tarsia P, Canetta C, Graziadei G, et al. (2008). Severe asthma exacerbation: role of acute Chlamydophila pneumoniae and Mycoplasma pneumoniae infection. Respir. Res. 9: 48.
9. Fonseca-Aten M, Okada PJ, Bowlware KL, Chavez-Bueno S, et al. (2006). Effect of clarithromycin on cytokines and chemokines in children with an acute exacerbation of recurrent wheezing: a double-blind, randomized, placebo-controlled trial. Ann. Allergy Asthma Immunol. 97: 457-463.
10. Good JT Jr, Rollins DR and Martin RJ (2012). Macrolides in the treatment of asthma. Curr. Opin. Pulm. Med. 18: 76-84.
11. Groneberg DA, Harrison S, Dinh QT, Geppetti P, et al. (2006). Tachykinins in the respiratory tract. Curr. Drug Targets 7: 1005-1010.
12. Guilbert TW and Denlinger LC (2010). Role of infection in the development and exacerbation of asthma. Expert. Rev. Respir. Med. 4: 71-83.
13. Hardy RD, Jafri HS, Olsen K, Wordemann M, et al. (2001). Elevated cytokine and chemokine levels and prolonged pulmonary airflow resistance in a murine Mycoplasma pneumoniae pneumonia model: a microbiologic, histologic, immunologic, and respiratory plethysmographic profile. Infect. Immun. 69: 3869-3876.
14. Hong SJ (2012). The role of Mycoplasma pneumoniae infection in asthma. Allergy Asthma Immunol. Res. 4: 59-61.
15. Jeong YC, Yeo MS, Kim JH, Lee HB, et al. (2012). Mycoplasma pneumoniae infection affects the serum levels of vascular endothelial growth factor and interleukin-5 in atopic children. Allergy Asthma Immunol. Res. 4: 92-97.
16. Korppi M (2010). Bacterial infections and pediatric asthma. Immunol. Allergy Clin. North Am. 30: 565-74.
17. Li M and Shang YX (2012). Inhaled corticosteroids inhibit substance P receptor expression in asthmatic rat airway smooth muscle cells. BMC Pulm. Med. 12: 79.
18. Li M, Shang YX, Wei B and Yang YG (2011). The effect of substance P on asthmatic rat airway smooth muscle cell proliferation, migration, and cytoplasmic calcium concentration in vitro. J. Inflamm. 8: 18.
19. Maffey AF, Barrero PR, Venialgo C, Fernandez F, et al. (2010). Viruses and atypical bacteria associated with asthma exacerbations in hospitalized children. Pediatr. Pulmonol. 45: 619-625.
20. Martin RJ, Chu HW, Honour JM and Harbeck RJ (2001). Airway inflammation and bronchial hyperresponsiveness after Mycoplasma pneumoniae infection in a murine model. Am. J. Respir. Cell Mol. Biol. 24: 577-582.
21. Medford AR (2012). Macrolides in asthma. Chest 141: 569-570.
22. Narita M and Tanaka H (2012). Late increase of interleukin-18 levels in blood during Mycoplasma pneumoniae pneumonia. Cytokine 59: 18-19.
23. Ou CY, Tseng YF, Chiou YH, Nong BR, et al. (2008). The role of Mycoplasma pneumoniae in acute exacerbation of asthma in children. Acta Paediatr. Taiwan 49: 14-18.
24. Ramalho R, Soares R, Couto N and Moreira A (2011). Tachykinin receptors antagonism for asthma: a systematic review. BMC Pulm. Med. 11: 41.
25. Satake H and Kawada T (2006). Overview of the primary structure, tissue-distribution, and functions of tachykinins and their receptors. Curr. Drug Targets 7: 963-974.
26. Sutherland ER and Martin RJ (2007). Asthma and atypical bacterial infection. Chest 132: 1962-1966.
27. Varshney AK, Chaudhry R, Saharan S, Kabra SK, et al. (2009). Association of Mycoplasma pneumoniae and asthma among Indian children. FEMS Immunol. Med. Microbiol. 56: 25-31.